急诊科检测与诊疗协调对治疗结局的决定作用(DETECT)丙型肝炎衔接照护试验:基于急诊科的丙型肝炎衔接照护策略随机临床试验的原理与设计
该文介绍DETECT丙型肝炎衔接照护试验的原理与设计:一项单中心前瞻性实效性随机两臂平行组优效性试验,在丹佛健康医疗中心急诊科比较衔接导航联合临床医生转诊与单独临床医生转诊对未治疗HCV阳性患者治疗启动的效果,计划最多入组280例HCV RNA阳性参与者,并设一次中期分析。
要点
- 试验比较衔接导航联合临床医生转诊与单独临床医生转诊,主要结局为治疗启动。
- 计划最多入组280例HCV RNA阳性参与者,设一次基于O'Brien-Fleming方法的中期分析。
- 研究在丹佛健康医疗中心急诊科开展,该院为城市安全网医院,年成人急诊就诊量约75,000例。
核心结论
- 试验完成后将为急诊科识别出的HCV患者如何最佳开展衔接照护提供重要信息。
研究设计与样本
- 单中心前瞻性实效性随机两臂平行组优效性试验,比较衔接导航联合临床医生转诊与单独临床医生转诊。
- 研究在丹佛健康医疗中心(科罗拉多州丹佛)急诊科开展,该院为城市安全网医院,年成人急诊就诊量约75,000例。
- 计划最多入组280例HCV RNA阳性参与者,设一次基于O'Brien和Fleming方法的中期分析。
主要发现
- 原文未报告结果数据。
关键数值与推荐
- 主要假设为衔接导航联合临床医生转诊在治疗启动(主要结局)方面优于单独临床医生转诊。
- 计划最多入组280例HCV RNA阳性参与者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hepatitis C (HCV) poses a major public health problem in the USA. While early identification is a critical priority, subsequent linkage to a treatment specialist is a crucial step that bridges diagnosed patients to treatment, cure, and prevention of ongoing transmission. Emergency departments (EDs) serve as an important clinical setting for HCV screening, although optimal methods of linkage-to-care for HCV-diagnosed individuals remain unknown. In this article, we describe the rationale and design of The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial. METHODS: The DETECT Hep C Linkage-to-Care Trial will be a single-center prospective comparative effectiveness randomized two-arm parallel-group superiority trial to test the effectiveness of linkage navigation and clinician referral among ED patients identified with untreated HCV with a primary hypothesis that linkage navigation plus clinician referral is superior to clinician referral alone when using treatment initiation as the primary outcome. Participants will be enrolled in the ED at Denver Health Medical Center (Denver, CO), an urban, safety-net hospital with approximately 75,000 annual adult ED visits. This trial was designed to enroll a maximum of 280 HCV RNA-positive participants with one planned interim analysis based on methods by O'Brien and Fleming. This trial will further inform the evaluation of cost effectiveness, disparities, and social determinants of health in linkage-to-care, treatment, and disease progression. DISCUSSION: When complete, the DETECT Hep C Linkage-to-Care Trial will significantly inform how best to perform linkage-to-care among ED patients identified with HCV. TRIAL REGISTRATION: ClinicalTrials.gov ID: NCT04026867 Original date: July 1, 2019 URL: https://clinicaltrials.gov/ct2/show/NCT04026867.
引用
- Rowan SE, Haukoos J, Kamis KF, et al. The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis C. Trials. 2023. PMID: 36707909. doi:10.1186/s13063-022-07018-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。